How to choose a progestogen for hormone therapy of the menopausal period?

Tomasz Pertyński; Grzegorz Stachowiak

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2008
vol. 7

Send email

Copy url:

abstract:

How to choose a progestogen for hormone therapy of the menopausal period?

Tomasz Pertyński

,

Grzegorz Stachowiak

Przegląd Menopauzalny 2008; 3: 132–137

Online publish date: 2008/07/07

View full text Get citation

The choice of a proper progestogen for hormone therapy (HT) of the menopausal period, including its dosage and route of administration, is a crucial element of so-called tailored therapy. Remembering all the indications and contraindications for this kind of treatment one should know that progestogens used in HT are a big group of compounds with different affinity for the receptors – progesterone, estrogen, androgen, mineral- and glucocorticoid – what results in different, in many cases even opposed, final metabolic effects. This knowledge allows to choose the best possible form of progestogen therapy and to avoid, or minimize, some side-effects connecting with this kind of hormone administration.

keywords:

How to choose a progestogen for hormone therapy of the menopausal period?

Tomasz Pertyński , Grzegorz Stachowiak

progestogens, hormone therapy, menopause, side-effects, indications, contraindications

Tomasz Pertyński

,

Grzegorz Stachowiak